T.C. Orton
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Peroxisome Proliferator-Activated Receptors 3
- Pluripotent Stem Cells Research 3
- Ion channel regulation and function 3
- Pharmacology 14
- Pharmacogenetics and Drug Metabolism 11
- Co-authors
- Oliver Flint (7 shared papers)M. Anderson (4 shared papers)R.D. Pickett (4 shared papers)Thomas E. Eling (4 shared papers)Graham R. Nunn (1 shared paper)J.C. Topham (1 shared paper)Peter Greaves (1 shared paper)Robert L. Fine (1 shared paper)
- Journals
- Carcinogenesis (6 papers)Journal of Pharmacology and Experimental Therapeutics (5 papers)Xenobiotica (3 papers)Drug Metabolism and Disposition (2 papers)Biochemical Pharmacology (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
T.C. Orton
39 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 105
- Pharmacology 317
- Cancer Research 289
- Health, Toxicology and Mutagenesis 225
- Small Animals 94
- Clinical Biochemistry 80
Countries citing papers authored by T.C. Orton
This map shows the geographic impact of T.C. Orton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.C. Orton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.C. Orton more than expected).
Fields of papers citing papers by T.C. Orton
This network shows the impact of papers produced by T.C. Orton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.C. Orton. The network helps show where T.C. Orton may publish in the future.
Co-authors
The 25 scholars most cited alongside T.C. Orton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Two-year carcinogenicity study of tamoxifen in Alderley Park Wistar-derived rats. | 1993 | 281 |
| 2 | 1984 | 186 | |
| 3 | Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. | 1995 | 175 |
| 4 | 1982 | 157 | |
| 5 | 1986 | 101 | |
| 6 | 1973 | 95 | |
| 7 | 1974 | 86 | |
| 8 | 1975 | 62 | |
| 9 | 1993 | 56 | |
| 10 | 1984 | 45 | |
| 11 | 1996 | 33 | |
| 12 | 1975 | 32 | |
| 13 | 1992 | 29 | |
| 14 | 2009 | 22 | |
| 15 | 1997 | 18 | |
| 16 | 1993 | 16 | |
| 17 | 1986 | 16 | |
| 18 | 1994 | 15 | |
| 19 | 1972 | 15 | |
| 20 | 1996 | 15 |
About T.C. Orton
T.C. Orton is a scholar working on Molecular Biology, Pharmacology, Oncology, Endocrinology, Diabetes and Metabolism and Genetics, having authored 40 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (5 papers), Hormonal Regulation and Hypertension (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Estrogen and related hormone effects (3 papers), Pluripotent Stem Cells Research (3 papers), Cancer Treatment and Pharmacology (3 papers) and Ion channel regulation and function (3 papers). The work is most often cited by research in Pharmacology (317 citations), Cancer Research (289 citations), Health, Toxicology and Mutagenesis (225 citations), Small Animals (94 citations) and Clinical Biochemistry (80 citations). T.C. Orton has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Oliver Flint, M. Anderson, R.D. Pickett, Thomas E. Eling, Graham R. Nunn, J.C. Topham, Peter Greaves, Robert L. Fine, Angus T. De Souza and Gerald R. Hankins. Their work appears in journals such as Carcinogenesis, Journal of Pharmacology and Experimental Therapeutics, Xenobiotica, Drug Metabolism and Disposition and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.